Population Pharmacokinetics and Pharmacodynamics of Fepixnebart (LY3016859) and Epiregulin in Patients with Chronic Pain
Authors
- Douglas E. James
- Julia Winkler (ORCID: https://orcid.org/0009-0000-0085-6480)
- Jason A. Bailey (ORCID: https://orcid.org/0000-0001-9335-2766)
- Rik C. Schoemaker (ORCID: https://orcid.org/0000-0002-7538-3005)
- Jan‐Stefan van der Walt (ORCID: https://orcid.org/0000-0002-6790-0172)
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- Clinical Pharmacokinetics
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1007/s40262-025-01506-3
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company